Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-11-10

著者

• ITOH Kyogo

  Departments of Immunology, Kurume University School of Medicine

• NOGUCHI Masanori

  Department of Urology, Kurume University School of Medicine

• Itoh Kyogo

  近畿大学 医学部泌尿器科学

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka

• Itoh Kyogo

  久留米大学 医学部免疫学

• Itoh K

  Kurume Univ. School Of Medicine Fukuoka Jpn

• SHICHIJO Shigeki

  Department of Immunology, Kurume University School of Medicine

• KOMATSU Nobukazu

  Department of Immunology, Kurume University School of Medicine

• Itoh K

  Department Of Immunology Kurume University School Of Medicine

• Itoh Kyogo

  Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen

• Itoh Kyogo

  Division Of Cancer Vaccine Development At The Research Center For Innovative Cancer Therapy Kurume U

• Itoh Kyogo

  Department Of Immunology

• Itoh Kyogo

  Department Of Lmmunology Kurume University School Of Medicine

• Shichijo S

  Department Of Immunology Kurume University School Of Medicine

• Shichijo Shigeki

  Departments Of Immunology

• NIU Yamei

  Department of Immunology and Immunotherapy, Kurume University School of Medicine

• TERASAKI Yasunobu

  Department of Immunology and Immunotherapy, Kurume University School of Medicine

• Niu Yamei

  Department Of Immunology And Immunotherapy Kurume University School Of Medicine

• Nishikori M

  Department Of Urology Kurume University School Of Medicine

• Noguchi Masanori

  Department Of Urology

• Komatsu Nobukazu

  Department Of Immunology Kurume University School Of Medicine

• Komatsu Nobukazu

  Department Of Immunology And Immunotherapy Kurume University School Of Medicine

• Shichijo Shigeki

  Department Of Immunology And Immunotherapy Kurume University School Of Medicine

• Terasaki Yasunobu

  Department Of Immunology And Immunotherapy Kurume University School Of Medicine

• Noguchi Masanori

  Department of Health Promotion and Education, Osaka Medical Center for Health Science and Promotion

関連論文

• Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
• New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
• Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
• Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy : Efficacy in Japanese male patients with ureteral stone
• Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
• Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
• Immunological evaluation of personalized peptide vaccination monotherapy in patients with castration-resistant prostate cancer
• Criteria of Applicability of Laser Thomson Scattering Measurements ofElectron Properties in Reactive Plasmas
• A Thomson Scattering Measurement System based on an Infrared laser
• Detection Limit of Laser Thomson Scattering for Low Density Discharge Plasmas
• Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer
• Cytotoxicity Induced by Erythrina variegata Serine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
• Personalized peptide vaccines : A new therapeutic modality for cancer
• Expression of Tumor-rejection Antigens in Gynecologic Cancers
• Expression of the SART-1 Antigens in Uterine Cancers
• Target molecules in specific immunotherapy against prostate cancer
• Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients
• Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
• Expression of MAGE-1 Gene by Esophageal Carcinomas
• Histocompatibility Leukocyte Antigen-A2402-restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor-infiltrating Lymphocytes of Patients with Colon Cancer
• Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
• Changes in the Mononuclear Cell Subpopulations of Rat Cardiac Transplant Recipients Administered FK506 for the Treatment of Ongoing Rejection
• Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
• Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
• Antibody Reactive to a Hepatitis C Virus (HCV)-Derived Peptide Capable of Inducing HLA-A2 Restricted Cytotoxic T Lymphocytes Is Detectable in a Majority of HCV-Infected Individuals without HLA-A2 Restriction
• Chemohormonal therapy as primary treatment for metastatic prostate cancer : A randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist
• Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide
• Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients
• Serine Proteinase Inhibitor 9 Can Be Recognized by Cytotoxic T Lymphocytes of Epithelial Cancer Patients
• Identification of Cyclophilin B-derived Peptides Capable of Inducing Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes
• Mouse Homologue of the Human SART3 Gene Encoding Tumor-rejection Antigen
• Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
• Spectroscopic Analysis of the Cytoagglutinating Activity of Abrin-b Isolated from Abrus precatorius Seeds against Leukemic Cells
• A GENE ENCODING SQUAMOUS CELL CARCINOMA ANTIGENS RECOGNIZED BY CYTOTOXIC T LYMPHOCYTE
• Genes Encoding Antigenic Peptides of Human Epithelial Cancers Recognized by Cytotoxic T Lymphocytes
• Detection of MAGE-4 Protein in Sera of Lung Cancer Patients
• Human Tumor Rejection Antigens MAGE1^1
• Cytokine Production by T Cells Infiltrating in the Eye of Uveitis Patients
• Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5-Aza-2'-deoxycytidine
• In Vitro Effects of Immunosuppressive Agents on Cytokine Production by HTLV-I-Infected T Cell Clones Derived from the Ocular Fluid of Patients with HTLV-I Uveitis
• Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanona antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease
• Retroperitoneal extragonadal germ cell tumor presenting as a bulky pelvic mass of the obturator fossa
• Laparoscopic adrenalectomy in patients with large adrenal tumors
• High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma
• Efficacy and safety of laparoscopic surgery for pheochromocytoma
• Necessity of repeat biopsies in men for suspected prostate cancer
• Therapeutic Efficacy of Clenbuterol for Urinary Incontinence after Radical Prostatectomy
• Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients
• Elevation of Serum MAGE-4 Protein Levels and Prediction of Hepatocellular Carcinogenesis in Patients with Liver Cirrhosis
• Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
• Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
• A questionnaire survey of patient preparation and techniques for prostate biopsy among urologists in the Kyushu and Okinawa regions of Japan
• Renal silica calculi in an infant
• Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy
• Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy
• Identification of peptides applicable as vaccines for HLA-A26-positive cancer patients
• Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer
• Treatment of Bilateral Staghorn Calculi by Endourology and Extracorporeal Shockwave Lithotripsy : Report of 4 Cases
• Early catheter removal 3 days after radical retropubic prostatectomy
• Clinical Study on Surgical Treatment of Vesicoureteral Reflux in Children
• Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection
• Transurethral Electrovaporization for Giant Prostatic Hyperplasia: Report of a Case
• Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination
• Evaluation of a prostate biopsy strategy for cancer detection using a computer simulation system with virtual needle biopsy for three-dimensional prostate models
• MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma : correlation with stage and grade, and comparison with urinary cytology
• Guidelines for Smoking Cessation (JCS 2010) : Digest Version
• Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC)
• Exploring immune therapy for renal cancer
• Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli
• Surgical procedures for benign prostatic hyperplasia : A nationwide survey in Japan
• Unusual presentation of intraparenchymal renal artery aneurysm mimicking cystic renal cell carcinoma : A case report
• Successful Treatment of T4 Renal Cell Carcinoma After a Neoadjuvant Targeted Therapy Using Sunitinib: Report of a Case
• Bilateral Neurovascular Bundles Sparing Prostatectomy Preserves Sexual Function in Patients with Localized Prostate Cancer
• Development of a New Diagnostic Tool for Pancreatic Cancer: Simultaneous Measurement of Antibodies against Peptides Recognized by Cytotoxic T Lymphocytes
• Increase in the Capability of Interleukin 2 Gene-Transduced Renal Cell Carcinoma Cells to Induce Cytotoxic Lymphocytes.
• Comparison between Natural and Immunized Anti-GM1 Antibodies Analyzed by Marker Releasing Rate Assay with Liposome.
• Suspension Technique Improves Rapid Recovery of Urinary Continence Following Radical Retropubic Prostatectomy
• Haptoglobin Proved a Prognostic Biomarker in Peripheral Blood of Patients with Personalized Peptide Vaccinations for Advanced Castration-Resistant Prostate Cancer

もっと見る 閉じる

スポンサーリンク